Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

212 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

NCT00055562

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Southern California Norris Cancer Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • St. Francis Memorial Hospital San Francisco, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

NCT04975308

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +7 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 243 locations
View Trial Details
Active, Not Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

NCT04886804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • City of Hope-Duarte-56419 Duarte, California, United States
  • City of Hope - Seacliff Huntington Beach, California, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

NCT05288166

Conditions
Abiraterone Acetate, Androgens, Antineoplastic Agents, +27 more
Locations
  • Arizona Oncology Associates, P.C. - HOPE Prescott, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Prescott Valley, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
View all 266 locations
View Trial Details
Active, Not Recruiting

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

NCT05440786

Conditions
Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • Washington University St Louis, Missouri, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

NCT05169567

Conditions
Breast Diseases, Breast Neoplasm, Breast Neoplasms, +8 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
View all 138 locations
View Trial Details
Active, Not Recruiting

A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)

NCT06460961

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Atlantic Health System Morristown Medical Center ( Site 4001) Morristown, New Jersey, United States
  • Providence Portland Medical Center ( Site 4002) Portland, Oregon, United States
  • South Texas Accelerated Research Therapeutics (START) ( Site 4003) San Antonio, Texas, United States
  • Westmead Hospital ( Site 1002) Westmead, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

NCT00781612

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Can Care Assoc Med Group Inc Redondo Beach, California, United States
  • Univ of Calif, San Francisco San Francisco, California, United States
  • Central Coast Medical Oncology San Luis Obispo, California, United States
View all 178 locations
View Trial Details

Related conditions